Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Clinical trial NCT00387270 · COMPLETED
Trial details
- NCT number
- NCT00387270
- Sponsor
- Medivation, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.